Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Amol K. Narang"'
Autor:
I-Chia Liu, MD, Susan Gearhart, MD MEd, Suqi Ke, MS, Chen Hu, PhD MS, Haniee Chung, MD, Jonathan Efron, MD, Alodia Gabre-Kidan, MD MPH, Peter Najjar, MD MBA, Chady Atallah, MD, Bashar Safar, MD, Eric S. Christenson, MD, Nilofer S. Azad, MD, Valerie Lee, MD, Atif Zaheer, MD, Jacqueline E. Birkness-Gartman, MD, Abhinav V. Reddy, MD, Amol K. Narang, MD, Jeffrey Meyer, MD MS
Publikováno v:
Surgery Open Science, Vol 18, Iss , Pp 42-49 (2024)
Background: Total neoadjuvant therapy (TNT) is an accepted approach for the management of locally advanced rectal cancer (LARC) and is associated with a decreased risk of development of metastatic disease compared to standard neoadjuvant therapy. How
Externí odkaz:
https://doaj.org/article/f56d4f51e4e94956af647a79a5ceec3e
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionPatients with localized pancreatic adenocarcinoma (PDAC) benefit from multi-modality therapy. Whether care patterns and oncologic outcomes vary if a patient was seen through a pancreatic multi-disciplinary clinic (PMDC) versus only indivi
Externí odkaz:
https://doaj.org/article/7b8b026c0af3417286dd82010db6be5b
Autor:
Manoop S. Bhutani, Amol K. Narang, Kai Ding, Brenna Casey, Kumar Krishnan, Eugene J. Koay, Theodore S. Hong, Joseph M. Herman, Kristen H. Griffin, Eun Ji Shin
Publikováno v:
Endoscopy International Open, Vol 12, Iss 07, Pp E861-E867 (2024)
Externí odkaz:
https://doaj.org/article/9ca876c7bb074d1390882e487ee42e97
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background Localized pancreatic adenocarcinoma carries a poor prognosis even after aggressive therapy. Up to 40% of patients may develop locoregional disease as the first site of failure. As such, there may be a role for intensification of l
Externí odkaz:
https://doaj.org/article/31c0b3e5e265442c8bc4c670514bdfe9
Autor:
Abhinav V. Reddy, Shuchi Sehgal, Colin S. Hill, Lei Zheng, Jin He, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Publikováno v:
Current Oncology, Vol 29, Iss 1, Pp 308-320 (2022)
Objective: To report on clinical outcomes and toxicity in older (age ≥ 70 years) patients with localized pancreatic cancer treated with upfront chemotherapy followed by stereotactic body radiation therapy (SBRT) with or without surgery. Methods: En
Externí odkaz:
https://doaj.org/article/fc04a507b6104acd883596453c54e166
Autor:
Abhinav V. Reddy, Matthew P. Deek, Juan F. Jackson, Colin S. Hill, Shuchi Sehgal, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Objectives The purpose of this study was to determine if vertebral body and splenic dosimetry was associated with the development of lymphopenia in patients with borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC) trea
Externí odkaz:
https://doaj.org/article/61edb4879a494aa39a3495b8e38c1563
Autor:
Colin S. Hill, Sarah Han-Oh, Zhi Cheng, Ken Kang-Hsin Wang, Jeffrey J. Meyer, Joseph M. Herman, Amol K. Narang
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Purpose Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy (SBRT) for pancreatic adenocarcinoma (PDAC). While on-board imaging for fiduci
Externí odkaz:
https://doaj.org/article/b2877cfccc3d4f49ba3585cdabcc1600
Autor:
Zhi Cheng, MD, MPH, Lauren M. Rosati, BS, Linda Chen, MD, Omar Y. Mian, MD, PhD, Yilin Cao, MD, Marta Villafania, BS, Minoru Nakatsugawa, PhD, Joseph A. Moore, PhD, Scott P. Robertson, PhD, Juan Jackson, BS, Amy Hacker-Prietz, PA-C, Jin He, MD, PhD, Christopher L. Wolfgang, MD, PhD, Matthew J. Weiss, MD, Joseph M. Herman, MD, MS, Amol K. Narang, MD, Todd R. McNutt, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 4, Pp 601-610 (2018)
Purpose: For patients with localized pancreatic cancer (PC) with vascular involvement, prediction of resectability is critical to define optimal treatment. However, the current definitions of borderline resectable (BR) and locally advanced (LA) disea
Externí odkaz:
https://doaj.org/article/15136fc206b645099c2da69bb6fdbe95
Autor:
Kathryn J. Schunke, PhD, Lauren M. Rosati, BS, Marianna Zahurak, MS, Joseph M. Herman, MD, MSc, Amol K. Narang, MD, Irina Usach, Alison P. Klein, MHS, PhD, Charles J. Yeo, MD, Larry T. Korman, BSN, Ralph H. Hruban, MD, John L. Cameron, MD, Daniel A. Laheru, MD, Ross A. Abrams, MD
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 1, Pp 42-51 (2018)
Purpose: The purpose of this study was to report toxicity and long-term survival outcomes of 2 prospective trials evaluating mitomycin C (MMC) with 5-fluorouracil–based adjuvant chemoradiation in resected periampullary adenocarcinoma. Methods and m
Externí odkaz:
https://doaj.org/article/70f9f35e04b1417eaac32619b7d7d0c1
Autor:
Dana K. Andersen, Robert C. Miller, Ralph H. Hruban, Matthew T. Olson, Fred E. Eckhauser, Dan Laheru, John L. Cameron, Joseph M. Herman, Amol K. Narang, Aaron S. Mansfield, Jordan M. Winter
Publikováno v:
Rare Tumors, Vol 3, Iss 1, Pp e5-e5 (2011)
Primary pancreatic small cell carcinoma (SCC) is rare, with just over 30 cases reported in the literature. Only 7 of these patients underwent surgical resection with a median survival of 6 months. Prognosis of SCC is therefore considered to be poor,
Externí odkaz:
https://doaj.org/article/ca01a53047b046c693eda488b5c9bd67